Follow the people · Insider
Mark Schoenberg
Mark Schoenberg files insider transactions with the SEC as a chief medical officer of UroGen Pharma (URGN). We hold 6 disclosed purchases and sales filed since 29 January 2019, 3 of them in the last 90 days.
- Files forURGN
- Disclosed buys and sells6 in all, 3 in the last 90 days
- Last disclosure24 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 26 January 2019 — 20 August 2026Chief Medical Officer · UroGen Pharma (URGN)171 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 60,677 shares of UroGen PharmaSEC Form 424 August 2026ordinary shares · traded 20 August 2026 · filed 24 August 2026
- ▼ sold on the open market 10,000 shares of UroGen PharmaSEC Form 410 July 2026Ordinary Shares · traded 9 July 2026 · filed 10 July 2026
- ▼ sold on the open market 10,000 shares of UroGen PharmaSEC Form 424 June 2026Ordinary Shares · traded 22 June 2026 · filed 24 June 2026
- exercised options over 10,000 shares of UroGen PharmaSEC Form 49 June 2026Ordinary Shares · traded 8 June 2026 · filed 9 June 2026
- ▼ sold on the open market 5,222 shares of UroGen PharmaSEC Form 49 June 2026Ordinary Shares · traded 8 June 2026 · filed 9 June 2026
- exercised options over 10,000 shares of UroGen Pharma (a derivative holding)SEC Form 49 June 2026Restricted Stock Units · traded 8 June 2026 · filed 9 June 2026
- ▼ sold on the open market 10,000 shares of UroGen PharmaSEC Form 411 May 2026Ordinary Shares · traded 8 May 2026 · filed 11 May 2026
- ▼ sold on the open market 1,844 shares of UroGen PharmaSEC Form 44 February 2026Ordinary Shares · traded 3 February 2026 · filed 4 February 2026
- ▼ sold on the open market 1,843 shares of UroGen PharmaSEC Form 44 February 2026Ordinary Shares · traded 3 February 2026 · filed 4 February 2026
- ▼ sold on the open market 3,686 shares of UroGen PharmaSEC Form 44 February 2026Ordinary Shares · traded 3 February 2026 · filed 4 February 2026
- ▼ sold on the open market 1,844 shares of UroGen PharmaSEC Form 44 February 2026Ordinary Shares · traded 3 February 2026 · filed 4 February 2026
- ▼ sold on the open market 1,843 shares of UroGen PharmaSEC Form 44 February 2026Ordinary Shares · traded 3 February 2026 · filed 4 February 2026
- ▼ sold on the open market 3,686 shares of UroGen PharmaSEC Form 44 February 2026Ordinary Shares · traded 3 February 2026 · filed 4 February 2026
- exercised options over 3,333 shares of UroGen PharmaSEC Form 43 February 2026Ordinary Shares · traded 31 January 2026 · filed 3 February 2026
- exercised options over 6,666 shares of UroGen PharmaSEC Form 43 February 2026Ordinary Shares · traded 31 January 2026 · filed 3 February 2026
- exercised options over 3,334 shares of UroGen PharmaSEC Form 43 February 2026Ordinary Shares · traded 31 January 2026 · filed 3 February 2026
- exercised options over 3,333 shares of UroGen Pharma (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 31 January 2026 · filed 3 February 2026
- exercised options over 6,666 shares of UroGen Pharma (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 31 January 2026 · filed 3 February 2026
- exercised options over 3,334 shares of UroGen Pharma (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 31 January 2026 · filed 3 February 2026
- was granted 20,000 shares of UroGen Pharma (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 31 January 2026 · filed 3 February 2026
- exercised options over 3,333 shares of UroGen Pharma (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 31 January 2026 · filed 3 February 2026
- exercised options over 6,666 shares of UroGen Pharma (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 31 January 2026 · filed 3 February 2026
- exercised options over 3,334 shares of UroGen Pharma (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 31 January 2026 · filed 3 February 2026
- was granted 20,000 shares of UroGen Pharma (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 31 January 2026 · filed 3 February 2026
- exercised options over 3,333 shares of UroGen PharmaSEC Form 43 February 2026Ordinary Shares · traded 31 January 2026 · filed 3 February 2026
- exercised options over 6,666 shares of UroGen PharmaSEC Form 43 February 2026Ordinary Shares · traded 31 January 2026 · filed 3 February 2026
- exercised options over 3,334 shares of UroGen PharmaSEC Form 43 February 2026Ordinary Shares · traded 31 January 2026 · filed 3 February 2026
- ▼ sold on the open market 10,000 shares of UroGen PharmaSEC Form 420 November 2025Ordinary Shares · traded 19 November 2025 · filed 20 November 2025
- exercised options over 1,667 shares of UroGen Pharma (a derivative holding)SEC Form 49 September 2025Restricted Stock Units · traded 7 September 2025 · filed 9 September 2025
- exercised options over 1,667 shares of UroGen PharmaSEC Form 49 September 2025Ordinary Shares · traded 7 September 2025 · filed 9 September 2025
- ▼ sold on the open market 871 shares of UroGen PharmaSEC Form 49 September 2025Ordinary Shares · traded 8 September 2025 · filed 9 September 2025
- ▼ sold on the open market 10,000 shares of UroGen PharmaSEC Form 413 August 2025Ordinary Shares · traded 11 August 2025 · filed 13 August 2025
- exercised options over 10,000 shares of UroGen PharmaSEC Form 430 July 2025Ordinary Shares · traded 28 July 2025 · filed 30 July 2025
- ▼ sold on the open market 5,149 shares of UroGen PharmaSEC Form 430 July 2025Ordinary Shares · traded 28 July 2025 · filed 30 July 2025
- exercised options over 10,000 shares of UroGen Pharma (a derivative holding)SEC Form 411 June 2025Restricted Stock Units · traded 8 June 2025 · filed 11 June 2025
- exercised options over 10,000 shares of UroGen PharmaSEC Form 411 June 2025Ordinary Shares · traded 8 June 2025 · filed 11 June 2025
- ▼ sold on the open market 5,162 shares of UroGen PharmaSEC Form 411 June 2025Ordinary Shares · traded 9 June 2025 · filed 11 June 2025
- exercised options over 1,334 shares of UroGen Pharma (a derivative holding)SEC Form 44 February 2025Restricted Stock Units · traded 31 January 2025 · filed 4 February 2025
- exercised options over 3,333 shares of UroGen Pharma (a derivative holding)SEC Form 44 February 2025Restricted Stock Units · traded 31 January 2025 · filed 4 February 2025
- exercised options over 3,333 shares of UroGen Pharma (a derivative holding)SEC Form 44 February 2025Restricted Stock Units · traded 31 January 2025 · filed 4 February 2025
- was granted 20,000 shares of UroGen Pharma (a derivative holding)SEC Form 44 February 2025Restricted Stock Units · traded 31 January 2025 · filed 4 February 2025
- exercised options over 1,334 shares of UroGen PharmaSEC Form 44 February 2025Ordinary Shares · traded 31 January 2025 · filed 4 February 2025
- ▼ sold on the open market 759 shares of UroGen PharmaSEC Form 44 February 2025Ordinary Shares · traded 31 January 2025 · filed 4 February 2025
- exercised options over 3,333 shares of UroGen PharmaSEC Form 44 February 2025Ordinary Shares · traded 31 January 2025 · filed 4 February 2025
- ▼ sold on the open market 1,896 shares of UroGen PharmaSEC Form 44 February 2025Ordinary Shares · traded 31 January 2025 · filed 4 February 2025
- exercised options over 3,333 shares of UroGen PharmaSEC Form 44 February 2025Ordinary Shares · traded 31 January 2025 · filed 4 February 2025
- ▼ sold on the open market 1,896 shares of UroGen PharmaSEC Form 44 February 2025Ordinary Shares · traded 31 January 2025 · filed 4 February 2025
- exercised options over 1,666 shares of UroGen Pharma (a derivative holding)SEC Form 412 September 2024Restricted Stock Units · traded 9 September 2024 · filed 12 September 2024
- exercised options over 1,666 shares of UroGen PharmaSEC Form 412 September 2024Ordinary Shares · traded 9 September 2024 · filed 12 September 2024
- ▼ sold on the open market 859 shares of UroGen PharmaSEC Form 412 September 2024Ordinary Shares · traded 9 September 2024 · filed 12 September 2024
- exercised options over 10,000 shares of UroGen Pharma (a derivative holding)SEC Form 411 June 2024Restricted Stock Units · traded 10 June 2024 · filed 11 June 2024
- exercised options over 10,000 shares of UroGen PharmaSEC Form 411 June 2024Ordinary Shares · traded 10 June 2024 · filed 11 June 2024
- ▼ sold on the open market 5,153 shares of UroGen PharmaSEC Form 411 June 2024Ordinary Shares · traded 10 June 2024 · filed 11 June 2024
- ▼ sold on the open market 12,000 shares of UroGen PharmaSEC Form 420 March 2024Ordinary Shares · traded 18 March 2024 · filed 20 March 2024
- ▼ sold on the open market 1,137 shares of UroGen PharmaSEC Form 45 February 2024Ordinary Shares · traded 1 February 2024 · filed 5 February 2024
- ▼ sold on the open market 758 shares of UroGen PharmaSEC Form 45 February 2024Ordinary Shares · traded 1 February 2024 · filed 5 February 2024
- ▼ sold on the open market 1,894 shares of UroGen PharmaSEC Form 45 February 2024Ordinary Shares · traded 1 February 2024 · filed 5 February 2024
- exercised options over 2,000 shares of UroGen Pharma (a derivative holding)SEC Form 42 February 2024Restricted Stock Units · traded 31 January 2024 · filed 2 February 2024
- exercised options over 1,333 shares of UroGen Pharma (a derivative holding)SEC Form 42 February 2024Restricted Stock Units · traded 31 January 2024 · filed 2 February 2024
- exercised options over 3,333 shares of UroGen Pharma (a derivative holding)SEC Form 42 February 2024Restricted Stock Units · traded 31 January 2024 · filed 2 February 2024
- was granted 10,000 shares of UroGen Pharma (a derivative holding)SEC Form 42 February 2024Restricted Stock Units · traded 31 January 2024 · filed 2 February 2024
- exercised options over 2,000 shares of UroGen PharmaSEC Form 42 February 2024Ordinary Shares · traded 31 January 2024 · filed 2 February 2024
- ▼ sold on the open market 1,137 shares of UroGen PharmaSEC Form 42 February 2024Ordinary Shares · traded 31 January 2024 · filed 2 February 2024
- exercised options over 1,333 shares of UroGen PharmaSEC Form 42 February 2024Ordinary Shares · traded 31 January 2024 · filed 2 February 2024
- ▼ sold on the open market 758 shares of UroGen PharmaSEC Form 42 February 2024Ordinary Shares · traded 31 January 2024 · filed 2 February 2024
- exercised options over 3,333 shares of UroGen PharmaSEC Form 42 February 2024Ordinary Shares · traded 31 January 2024 · filed 2 February 2024
- ▼ sold on the open market 1,894 shares of UroGen PharmaSEC Form 42 February 2024Ordinary Shares · traded 31 January 2024 · filed 2 February 2024
- was granted 5,000 shares of UroGen Pharma (a derivative holding)SEC Form 48 September 2023Restricted Stock Units · traded 7 September 2023 · filed 8 September 2023
- was granted 30,000 shares of UroGen Pharma (a derivative holding)SEC Form 49 June 2023Restricted Stock Units · traded 8 June 2023 · filed 9 June 2023
- exercised options over 500 shares of UroGen Pharma (a derivative holding)SEC Form 42 February 2023Restricted Stock Units · traded 31 January 2023 · filed 2 February 2023
- exercised options over 2,000 shares of UroGen Pharma (a derivative holding)SEC Form 42 February 2023Restricted Stock Units · traded 31 January 2023 · filed 2 February 2023
- exercised options over 1,333 shares of UroGen Pharma (a derivative holding)SEC Form 42 February 2023Restricted Stock Units · traded 31 January 2023 · filed 2 February 2023
- was granted 10,000 shares of UroGen Pharma (a derivative holding)SEC Form 42 February 2023Restricted Stock Units · traded 31 January 2023 · filed 2 February 2023
- was granted 30,000 shares of UroGen Pharma (a derivative holding)SEC Form 42 February 2023Employee Stock Option (right to buy) · traded 31 January 2023 · filed 2 February 2023
- exercised options over 500 shares of UroGen PharmaSEC Form 42 February 2023Ordinary Shares · traded 31 January 2023 · filed 2 February 2023
- ▼ sold on the open market 248 shares of UroGen PharmaSEC Form 42 February 2023Ordinary Shares · traded 31 January 2023 · filed 2 February 2023
- exercised options over 2,000 shares of UroGen PharmaSEC Form 42 February 2023Ordinary Shares · traded 31 January 2023 · filed 2 February 2023
- ▼ sold on the open market 991 shares of UroGen PharmaSEC Form 42 February 2023Ordinary Shares · traded 31 January 2023 · filed 2 February 2023
- exercised options over 1,333 shares of UroGen PharmaSEC Form 42 February 2023Ordinary Shares · traded 31 January 2023 · filed 2 February 2023
- ▼ sold on the open market 661 shares of UroGen PharmaSEC Form 42 February 2023Ordinary Shares · traded 31 January 2023 · filed 2 February 2023
- exercised options over 122,677 shares of UroGen Pharma (a derivative holding)SEC Form 423 January 2023Employee Stock Option (right to buy) · traded 20 January 2023 · filed 23 January 2023
- exercised options over 122,677 shares of UroGen PharmaSEC Form 423 January 2023Ordinary Shares · traded 20 January 2023 · filed 23 January 2023
- exercised options over 500 shares of UroGen Pharma (a derivative holding)SEC Form 42 November 2022Restricted Stock Units · traded 31 October 2022 · filed 2 November 2022
- exercised options over 500 shares of UroGen PharmaSEC Form 42 November 2022Ordinary Shares · traded 31 October 2022 · filed 2 November 2022
- ▼ sold on the open market 258 shares of UroGen PharmaSEC Form 42 November 2022Ordinary Shares · traded 31 October 2022 · filed 2 November 2022
- exercised options over 500 shares of UroGen Pharma (a derivative holding)SEC Form 425 August 2022Restricted Stock Units · traded 31 July 2022 · filed 25 August 2022
- exercised options over 500 shares of UroGen PharmaSEC Form 425 August 2022Ordinary Shares · traded 31 July 2022 · filed 25 August 2022
- ▼ sold on the open market 259 shares of UroGen PharmaSEC Form 425 August 2022Ordinary Shares · traded 1 August 2022 · filed 25 August 2022
- exercised options over 500 shares of UroGen Pharma (a derivative holding)SEC Form 43 May 2022Restricted Stock Units · traded 30 April 2022 · filed 3 May 2022
- exercised options over 500 shares of UroGen PharmaSEC Form 43 May 2022Ordinary Shares · traded 30 April 2022 · filed 3 May 2022
- ▼ sold on the open market 254 shares of UroGen PharmaSEC Form 43 May 2022Ordinary Shares · traded 30 April 2022 · filed 3 May 2022
- exercised options over 500 shares of UroGen Pharma (a derivative holding)SEC Form 42 February 2022Restricted Stock Units · traded 31 January 2022 · filed 2 February 2022
- was granted 12,064 shares of UroGen Pharma (a derivative holding)SEC Form 42 February 2022Stock Option (right to buy) · traded 31 January 2022 · filed 2 February 2022
- was granted 4,000 shares of UroGen Pharma (a derivative holding)SEC Form 42 February 2022Restricted Stock Units · traded 31 January 2022 · filed 2 February 2022
- exercised options over 2,000 shares of UroGen Pharma (a derivative holding)SEC Form 42 February 2022Restricted Stock · traded 31 January 2022 · filed 2 February 2022
- exercised options over 500 shares of UroGen PharmaSEC Form 42 February 2022Ordinary Shares · traded 31 January 2022 · filed 2 February 2022
- ▼ sold on the open market 275 shares of UroGen PharmaSEC Form 42 February 2022Ordinary Shares · traded 31 January 2022 · filed 2 February 2022
- exercised options over 2,000 shares of UroGen PharmaSEC Form 42 February 2022Ordinary Shares · traded 31 January 2022 · filed 2 February 2022
- ▼ sold on the open market 1,099 shares of UroGen PharmaSEC Form 42 February 2022Ordinary Shares · traded 31 January 2022 · filed 2 February 2022
- exercised options over 209 shares of UroGen Pharma (a derivative holding)SEC Form 428 January 2022Restricted Stock Units · traded 26 January 2022 · filed 28 January 2022
- exercised options over 209 shares of UroGen PharmaSEC Form 428 January 2022Ordinary Shares · traded 26 January 2022 · filed 28 January 2022
- ▼ sold on the open market 111 shares of UroGen PharmaSEC Form 428 January 2022Ordinary Shares · traded 26 January 2022 · filed 28 January 2022
- ▲ bought on the open market 160 shares of UroGen PharmaSEC Form 419 November 2021Ordinary Shares · traded 18 November 2021 · filed 19 November 2021
- exercised options over 500 shares of UroGen Pharma (a derivative holding)SEC Form 42 November 2021Restricted Stock Units · traded 31 October 2021 · filed 2 November 2021
- exercised options over 500 shares of UroGen PharmaSEC Form 42 November 2021Ordinary Shares · traded 31 October 2021 · filed 2 November 2021
- ▼ sold on the open market 258 shares of UroGen PharmaSEC Form 42 November 2021Ordinary Shares · traded 1 November 2021 · filed 2 November 2021
- exercised options over 208 shares of UroGen Pharma (a derivative holding)SEC Form 428 October 2021Restricted Stock Units · traded 26 October 2021 · filed 28 October 2021
- exercised options over 208 shares of UroGen PharmaSEC Form 428 October 2021Ordinary Shares · traded 26 October 2021 · filed 28 October 2021
- ▼ sold on the open market 107 shares of UroGen PharmaSEC Form 428 October 2021Ordinary Shares · traded 27 October 2021 · filed 28 October 2021
- exercised options over 500 shares of UroGen PharmaSEC Form 43 August 2021Ordinary Shares · traded 31 July 2021 · filed 3 August 2021
- ▼ sold on the open market 243 shares of UroGen PharmaSEC Form 43 August 2021Ordinary Shares · traded 2 August 2021 · filed 3 August 2021
- exercised options over 500 shares of UroGen Pharma (a derivative holding)SEC Form 43 August 2021Restricted Stock Units · traded 31 July 2021 · filed 3 August 2021
- exercised options over 208 shares of UroGen PharmaSEC Form 428 July 2021Ordinary Shares · traded 26 July 2021 · filed 28 July 2021
- ▼ sold on the open market 103 shares of UroGen PharmaSEC Form 428 July 2021Ordinary Shares · traded 26 July 2021 · filed 28 July 2021
- exercised options over 208 shares of UroGen Pharma (a derivative holding)SEC Form 428 July 2021Restricted Stock Units · traded 26 July 2021 · filed 28 July 2021
- exercised options over 500 shares of UroGen Pharma (a derivative holding)SEC Form 44 May 2021Restricted Stock Units · traded 30 April 2021 · filed 4 May 2021
- exercised options over 500 shares of UroGen PharmaSEC Form 44 May 2021Ordinary Shares · traded 30 April 2021 · filed 4 May 2021
- ▼ sold on the open market 243 shares of UroGen PharmaSEC Form 44 May 2021Ordinary Shares · traded 30 April 2021 · filed 4 May 2021
- exercised options over 209 shares of UroGen PharmaSEC Form 427 April 2021Ordinary Shares · traded 26 April 2021 · filed 27 April 2021
- ▼ sold on the open market 89 shares of UroGen PharmaSEC Form 427 April 2021Ordinary Shares · traded 26 April 2021 · filed 27 April 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.